BioAge Labs, Inc. (NASDAQ:BIOA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Healy Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Rapport Therapeutics, Inc. (Director · Since at least Jun 6, 2024); ArriVent BioPharma, Inc. (Director · Since at least Jan 25, 2024); Y mAbs Therapeutics (Director · Since at least Jun 12, 2019); CinCor Pharma Inc (Director · Jan 6, 2022 – Nov 28, 2022 · Past); Bolt Biotherapeutics, Inc. (Director · Feb 4, 2021 – Jun 12, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 18, 2024 · Past); Coherus Oncology, Inc. (Director · May 22, 2019 – Jan 7, 2022 · Past); Natera, Inc. (Director · Sep 14, 2018 – Apr 25, 2025 · Past) | Director · Since at least Sep 25, 2024 |
| Dov Goldstein Other companies: Coya Therapeutics, Inc. (Director · Since at least Dec 28, 2022); Gain Therapeutics, Inc. (Independent Member · Since at least Mar 17, 2021); NeuBase Therapeutics Inc (Director · Jul 12, 2019 – Sep 9, 2022 · Past); Loxo Oncology Inc (CFO and Treasurer · Jul 31, 2014 – Apr 1, 2015 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jun 6, 2018 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – Jul 24, 2012 · Past); ADMA Biologics Inc (Director · Feb 13, 2012 – Feb 28, 2020 · Past); Cempra Inc (Director · Feb 2, 2012 – Mar 7, 2017 · Past) | Chief Financial Officer · Since at least Sep 25, 2024 |
| Michael Davidson Other companies: NewAmsterdam Pharma Company N.V. (Chief Executive Officer · Since at least Dec 29, 2023); Tenax Therapeutics, Inc. (Board Director · Since at least Feb 25, 2021); Silence Therapeutics PLC (Director · Jan 2, 2025 – Jan 2, 2025 · Past); Lisata Therapeutics, Inc. (Director · Jul 28, 2020 – Jan 10, 2022 · Past); Omthera Pharmaceuticals Inc (Executive VP & CMO · Apr 11, 2013 – Jul 18, 2013 · Past) | Independent Director · Since at least Mar 26, 2024 |
| Jean-Pierre Garnier Other companies: Carrier Global Corporation (Independent Director · Since at least Apr 3, 2020); Radius Health, Inc. (Director · Dec 1, 2015 – Aug 15, 2022 · Past); RTX Corporation (Director · Mar 13, 2006 – Apr 29, 2019 · Past) | Chair of the Board · Since at least Aug 19, 2024 |
| Rekha Hemrajani Other companies: LB Pharmaceuticals Inc (Director · Since at least Sep 10, 2025); MaxCyte, Inc. (Non-Executive Director · Since at least Jun 29, 2022); ALX Oncology Holdings Inc. (Director · Since at least Jun 15, 2022) | Director · Since at least Apr 17, 2024 |
| Paul Rubin Other companies: Viridian Therapeutics, Inc. (EVP, Research & Development · Feb 13, 2017 – Feb 6, 2019 · Past) | CMO & EVP, Research · Since at least Sep 25, 2024 |
| Shane Barton Other companies: Precision BioSciences, Inc. (VP & Corporate Controller · Jan 1, 2021 – Jun 7, 2023 · Past) | SVP, Finance · Since at least Sep 25, 2024 |
| Vijay Pande Other companies: Nautilus Biotechnology, Inc. (Director · Jun 14, 2024 – Jun 14, 2024 · Past) | Director · Since at least Sep 25, 2024 |
| Ann Neale | Chief Development Officer · Since at least Nov 5, 2026 |
| BJ Sullivan | Chief Strategy Officer · Since at least Apr 13, 2026 |
| Chris Patil | VP, Media · Since at least Sep 8, 2026 |
| Eric Morgen | Co-Founder, COO · Since at least Jun 17, 2025 |
| George Hartman | SVP, Chemistry · Since at least Nov 5, 2026 |
| Joseph Rodgers | VP, Discovery Research · Since at least Nov 5, 2026 |
| Julie Gammelgard | SVP, People · Since at least Nov 5, 2026 |
| Kevin Wilhelmsen | VP, Biology · Since at least Nov 5, 2026 |
| Kristen Fortney | Co-Founder, CEO · Since at least Apr 17, 2024 |
| Naisha Shah | SVP, Data Science · Since at least Nov 5, 2026 |
| Nancy Mitchell-Sweeney | VP & Head of Clinical Operations · Since at least Nov 5, 2026 |
| Patrick Martin | SVP, Clinical Science · Since at least Nov 5, 2026 |
| Peng Leong | Chief Business Officer & Therapeutic Area Head, Brain Aging · Since at least Jun 16, 2026 |
| Rusty Montgomery | SVP, Research · Since at least Nov 5, 2026 |
| Sangita Ghosh | SVP, Technical Operations · Since at least Nov 5, 2026 |
| Yan Wang | SVP, Translational Aging Biology · Since at least Nov 5, 2026 |
| Yvonne Van Gessel | VP, Nonclinical Development · Since at least Nov 5, 2026 |